|Date & Time||11 March 2021 14.00 CET|
BRIDGE Translational Excellence Programme is a two-year postdoctoral fellowship in translational medicine and offers a few select graduated PhDs a two-year postdoctoral fellowship in translational medicine. A BRIDGE fellowship is a unique postdoctoral programme consisting of three core elements: education, mentoring and research.
We invite you to learn more on the programme on 11 March at 14.00 CET. Amongst the great speakers is our Scientific Director Toni Andreu.
- Toni Andreu – Scientific director of EATRIS, the European Infrastructure for Translational Medicine. Dr. Andreu has a research career in translational genetics and genomics of rare diseases and has served in multiple leading scientific and political roles advocating for science. Dr Andreu and EATRIS work to support and improve innovation and collaboration in the field of translational medicine throughout Europe.
- Kirsten Ohm Kyvik – Professor and Head of Institute of Clinical Medicine, University of Southern Denmark (SDU). Building on a research career in genetic epidemiology and metabolic disease, Prof Kyvik has been for a long time engaged with improving translational research at SDU and heavily involved in the structure and interaction between hospital and university.
- Paul R Conlin – Program Director, Clinical and Translational Research Academy (C/T RA), Harvard Catalyst, Chief, Medical Service, VA Boston Healthcare System and Professor of Medicine, Harvard Medical School. Prof. Conlin is an endocrinologist with a research career covering many aspects of Diabetes disease mechanisms and care. The C/T RA in the Harvard Catalyst programme, which Prof Conlin leads, has been a huge inspiration for the founding of the BRIDGE programme here in Copenhagen. Prof. Conlin has helped the BRIDGE team in their efforts to build such a programme from scratch, and he also serves on its International Advisory Board.
- Susan Slaugenhaupt – Scientific Director of the Massachusetts General Hospital in Boston, Professor in the Department of Neurology at MGH and Harvard Medical School, and Investigator in the Center for Genomic Medicine. Her research is involved with neurological and cardiac diseases and translational aspects in screening and novel therapies, and she has tremendous experience from MGH in their efforts in translational research and medical innovation.
Debate moderator: Miriam Kolko – Professor of at the University of Copenhagen and Chief Physician at the Dept. of Ophthalmology at Copenhagen University Hospital, Rigshospitalet Glostrup. Prof Kolko heads the Eye Translational Research Unit (EyeTRU) group working on cellular and translational aspects of glaucoma, and leads the Personalized Medicine Research Cluster at the Dept. of Drug Design and Pharmacology at Uni Copenhagen. Prof. Kolko also serves as BRIDGE mentor for Dr. Rupali Vohra.